#Glomerulardisease in children: when to #biopsy https://t.co/vKrl5sW6J2 #pediatric #NDTDigest

SGLT2i’s seem to be in the drinking water these days. Euglycemic DKA says hello now and then. This short, three-page editorial helps us manage this family of medications when these patients are in our ICU. 🎩 tip to the authors. https://t.co/Sfr6vCn6le

SGLT2 inhibitor (SGLT2i) Cold 🥶 Map: Indications for SGLT2i in CKD/ Albuminuria/ Type 2 Diabetes (T2D)/ Heart Failure (HFrEF, HFmrEF, HFpEF) from @ISNkidneycare @goKDIGO @RPANephrology @ASPCardio #Nephpearls #Cardiorenal 👉 https://t.co/6faeRc60mK

Prophylaxis in Glomerular Disease by Dr. Corey Cavanaugh Total live participants: 110 From 48 countries Watch the session here 👉 https://t.co/8cCmqGB027 #GlomCon

FSGS is not one disease! Looking forward to this talk by @fervenzafernan1 on how to dissect and approach the diagnosis and management of the various causes of FSGS 👇

This study shows chlorthalidone improved BP control among patients with advanced CKD independently of baseline urinary sodium, aldosterone, weight loss, or changes in the renin-angiotensin system https://t.co/qDEOscnhlB

Nonlupus full house nephropathy is a rare, complex entity. This study supports that SLE and nonlupus full house nephropathy are distinct clinical entities, with comparable outcomes https://t.co/YXJKi6CODa @AKronbichler

‼️ Pls join for an amazing talk on Amyloidosis facts and myths by Dr Leung ➡️August 28 2024, 4:30-5:30 EST @MSK_Neph @SheronLatcha #OncoNephrology

Comparison of Pros and Cons of #Dialysis Vascular Access Types. #MedEd #FOAMed Source: JAMA. 2024;331(15):1307-1317. PMID: 38497953.

🦋 Lupus Nephritis Classification @AJKDonline core curriculum

🔥IV iron and hypophosphatemia 🎯Mostly seen with ferric carboxylmaltose FCM How 🤔-FCM ➡️ FGF23 rise➡️ phosphate excretion 🆙 🙏Fortunately CKD pts at low risk➡️impaired GFR limits PO4 excretion in urine 🔥Suspect hypoPO4👆if a pt post IV iron➡️c/o myalgia/fatigue/bone

🔔New @goKDIGO guideline for lupus nephritis was published so fast after the last one! 📰What is the news, then? 💬 Let's discuss more on #NephJC chats on February 6 and 7 https://t.co/D9425xB724

💥ISOT- RENAL TRANSPLANT PATHOLOGY CERTIFICATE COURSE Get ready for 3️⃣rd webinar Topic: Chronic Active T cell mediated Rejection By Dr Radhika Krishna Patil 📆 17/01/24 🕰️ 06:30 PM #ISOTTxPath

Top Nephrology Stories for 2023 from @NephJC #Nephpearls #VisualGraphic by @priti899 👉🏼 https://t.co/y7ZwQjuXxj

🔥🫘Do you recommend low protein diet for your CKD patient (non dialysis Stage 3-5) 🤷‍♀️Difficult to decide 👍Theoretically Low protein diet(0.6-0.8 gm/Kg/day) -reduce intraglomerular pressure-⬇️GFR decline 👎😳Concerns of protein energy wasting and inadequate protein intake

🚨 Updated guidelines alert! The UKKA’s latest update on Treatment of Acute Hyperkalaemia in Adults brings crucial changes. From IV calcium salt rates to novel potassium binder use for moderate & severe cases, these changes are reshaping care standards. ➡️ https://t.co/zqMI66vWdd

The KDIGO 2024 Clinical Practice Guideline for the Management of #lupusnephritis is finally out! @ISNkidneycare @goKDIGO https://t.co/kZ8avsbcKF

Clinical Practice Guideline for the Management of Lupus Nephritis ca. 2024 from @goKDIGO #Nephpearls 📌 Immunosuppressive treatment for patients with Class I or Class II lupus nephritis 📌 Recommended approach for initial therapy of active Class III/IV lupus nephritis 📌

IKDRC Ahmedabad 2023 Total kidney Transplants 353 Deceased donors 155 (44%) Living related donor 147 Swap 43( of total 521 swap) Other than near related donors 8 44% deceased donors where national average is around 15% 22% of living donors are swap year 2000-2023 Total

So excited to share our @AJKDonline Core Curriculum with co-authors @danielwross4 & O'Neill is now online, a case-based approach showcasing how to incorporate US into clinical decision-making across the spectrum of kidney disease! Free, full text here: